Natixis’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-13,424
| Closed | -$689K | – | 797 |
|
|
2020
Q2 | $689K | Buy |
+13,424
| New | +$689K | 0.01% | 568 |
|
|
2020
Q1 | – | Sell |
-8,407
| Closed | -$503K | – | 753 |
|
|
2019
Q4 | $503K | Buy |
8,407
+876
| +12% | +$52.4K | ﹤0.01% | 714 |
|
|
2019
Q3 | $276K | Sell |
7,531
-14,032
| -65% | -$514K | ﹤0.01% | 744 |
|
|
2019
Q2 | $1M | Buy |
21,563
+9,095
| +73% | +$423K | 0.01% | 534 |
|
|
2019
Q1 | $500K | Sell |
12,468
-9,579
| -43% | -$384K | ﹤0.01% | 664 |
|
|
2018
Q4 | $1.01M | Buy |
22,047
+14,439
| +190% | +$664K | 0.01% | 510 |
|
|
2018
Q3 | $338K | Sell |
7,608
-436
| -5% | -$19.4K | ﹤0.01% | 675 |
|
|
2018
Q2 | $315K | Sell |
8,044
-835
| -9% | -$32.7K | ﹤0.01% | 755 |
|
|
2018
Q1 | $642K | Sell |
8,879
-1,198
| -12% | -$86.6K | ﹤0.01% | 644 |
|
|
2017
Q4 | $663K | Buy |
+10,077
| New | +$663K | 0.01% | 559 |
|